Quale sarebbe il prezzo per Solasia Pharma K.K. (4597)

Il prezzo per Solasia Pharma K.K. (4597) è $0.20877985

Qual è la capitalizzazione di mercato per Solasia Pharma K.K. (4597)

La capitalizzazione di mercato per Solasia Pharma K.K. (4597) è $57.00M

Solasia Pharma K.K. (4597) Prezzo e Capitalizzazione di Mercato

Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is dedicated to the development and commercialization of oncology treatments throughout Japan and other parts of Asia. The company's marketed products include SP-03 (episil oral liquid), designed for the protection and relief of oral pain and inflammation (mucositis/stomatitis) resulting from cancer chemotherapy and radiation. Additionally, they offer SP-01 (Sancuso), a transdermal patch that delivers granisetron, an anti-emetic, into the bloodstream to manage chemotherapy-induced nausea and vomiting. Solasia Pharma's development pipeline features SP-02 (Darinaparsin), a mitochondrial-targeted agent that has successfully completed Phase III clinical trials for a range of hematologic and solid cancers. Also in Phase III clinical study is SP-05 (Arfolitixorin), which aims to bolster the anti-tumor effectiveness of fluorouracil in various cancers, including pancreatic, breast, stomach, and head and neck cancers. In its pre-clinical stage, SP-04 is being developed to address chemotherapy-induced peripheral neuropathy.

Il prezzo per 4597	Attivo B	Capitalizzazione del mercato a B	Risultati
$19,255.33 $57.00M	NVDA	$5.257T	+9,222,689.99%
$16,844.41 $57.00M	AAPL	$4.599T	+8,067,923.66%
$15,042.01 $57.00M	GOOG	$4.107T	+7,204,622.15%
$13,103.13 $57.00M	MSFT	$3.577T	+6,275,948.87%
$10,282.88 $57.00M	AMZN	$2.807T	+4,925,127.16%

Il prezzo per 4597

Attivo B

Capitalizzazione del mercato a B

Risultati

$19,255.33 $57.00M